Eurazeo Growth Fund IV

About Eurazeo Growth Fund IV

Eurazeo Growth Fund IV is a venture capital firm based in France, focusing on Series C stage investments. The fund actively supports founders building innovative solutions in AI/ML, SaaS, providing strategic guidance and capital to help startups scale.

Investment Focus

Location / RegionFrance

Funding StageSeries C

Industry Focus

Ai Ml

Saas

Investor Signals Profile

active

Sweet Spot

Disruptive European growth-stage founder with impact angle

European mid-market

growth equity

healthcare/biotech

impact investing

venture

Bullish Signals

Biofund IV: €250M first closeexternal

ESMI II: €175M, above targetexternal

New Munich office, expanding Germanyexternal

Multi-strategy: Buyout, Growth, Venture, Healthcareexternal

Acquiring Netco Group from Ardianexternal

2024–2027 ambition: lead EU mid-marketexternal

Analyst workshop April 2026 — active LP engagementwebsite

Contrarian Signals

Large platform — slow decision cyclesexternal

French-headquartered, cultural fit mattersexternal

Geopolitical fragmentation flagged as key riskexternal

Power rivalries reshaping strategy — macro uncertaintywebsite

Founder Do's

Target European mid-market or growth stage

Align with impact or sustainability angle

Show disruptive or transformative model

Be ready for international scale

Open to Buyout, Acceleration, or Venture structures

Founder Don'ts

Don't pitch early pre-revenue concepts

Avoid non-European market focus

Don't ignore ESG/impact narrative

Key GPs & Partners

Christophe Bavière

Co-CEO

mid-market focusimpact-drivenEuropean growth

William Kadouch-Chassaing

Co-CEO

mid-market focusimpact-drivenEuropean growth

Unlock Investor Signals

$29/month for full signal access. Cancel anytime.

View Plans Browse all Signal Profiles →

Fund Overview

Fund Size€650M

Saves0

Website

Key People

Hala Fadel, William Kadouch Chassaing, Christophe Bavière

Christophe BavièreCo-CEO

William Kadouch-ChassaingCo-CEO